STSavvas Tsaramanidis

Savvas Tsaramanidis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Savvas Tsaramanidis has a total of 442 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot

    by Chiara D'ALterio, Quirino Lai, Maria Lanzone, Roberto Valente, Matteo Fabbrici da Correggio, Immacolata Iannone, Alessandro Coppola, Salah Berkane, Tomas Koltai, Lucas McCormack, et al.

  • Open Access

    Effect of unplanned conversion to open surgery on resection margins and postoperative complications in minimally-invasive resection of colorectal liver metastases: A systematic review and meta-analysis with meta-regression

    by Shahab Hajibandeh, Shahin Hajibandeh, Savvas Tsaramanidis, Amarah Mirza, Ajith Siriwardena, Saurabh Jamdar, Nicola De Liguori Carino, Thomas Satyadas

    Shahab Hajibandeh, Shahin Hajibandeh, Savvas Tsaramanidis, Amarah Shakeel Mirza, Ajith Kumar Siriwardena, Saurabh Jamdar, Nicola de Liguori Carino, Thomas Satyadas. Ann Hepatobiliary Pancreat Surg -0001;0:. https://doi.org/10.14701/ahbps.25-166

  • Open Access

    The Role of Branched-Chain Amino Acid Supplementation in Combination with Locoregional Treatments for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis

    by Georgios A. Sideris, Savvas Tsaramanidis, Aikaterini T. Vyllioti, Njogu Njuguna

    Background: Branched-chain amino acid (BCAA) supplementation has been linked with favorable outcomes in patients undergoing surgical or palliative treatments for hepatocellular carcinoma (HCC). To date, there has been no systematic review investigating the value of BCAA supplementation in HCC patients undergoing locoregional therapies. Materials and Methods: A systematic search of the literature was performed across five databases/registries using a detailed search algorithm according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement. The search was conducted on March 23, 2022. Results: Sixteen studies with a total of 1594 patients were analyzed. Most patients were male (64.6%) with a mean age of 68.2 ± 4.1 years, Child–Pugh score A (67.9%) and stage II disease (40.0%). Locoregional therapy consisted of radiofrequency ablation, transarterial chemoembolization or hepatic artery infusion chemotherapy. BCAA supplementation was in the form of BCAA granules or BCAA-enriched nutrient. Most studies reported improved albumin levels, non-protein respiratory quotient and quality of life in the BCAA group. Results pertaining to other outcomes including overall survival, recurrence rate, and Child–Pugh score were variable. Meta-analysis showed significantly higher levels of post-treatment serum albumin in the BCAA group (SMD = 0.54, 95% CI 0.20–0.87) but no significant differences in mortality rate (RR = 0.81, 95% CI: 0.65–1.02) and AST (SMD = −0.13, 95% CI: −0.43–0.18). Conclusion: BCAA supplementation is associated with higher post-treatment albumin levels. There are currently not sufficient data to support additional benefits. Further studies are needed to elucidate their value.


  • Open Access

    The Hellenic Emergency Laparotomy Study (HELAS): A Prospective Multicentre Study on the Outcomes of Emergency Laparotomy in Greece

    by Konstantinos Lasithiotakis, Evangelos I. Kritsotakis, Stamatios Kokkinakis, Georgia Petra, Konstantinos Paterakis, Garyfallia‐Apostolia Karali, Vironas Malikides, Charalampos S. Anastasiadis, Odysseas Zoras, Nikolas Drakos, et al.

    Background: Emergency laparotomy (EL) is accompanied by high post‐operative morbidity and mortality which varies significantly between countries and populations. The aim of this study is to report outcomes of emergency laparotomy in Greece and to compare them with the results of the National Emergency Laparotomy Audit (NELA).Methods: This is a multicentre prospective cohort study undertaken between 01.2019 and 05.2020 including consecutive patients subjected to EL in 11 Greek hospitals. EL was defined according to NELA criteria. Demographics, clinical variables, and post‐operative outcomes were prospectively registered in an online database. Multivariable logistic regression analysis was used to identify independent predictors of post‐operative mortality.Results: There were 633 patients, 53.9% males, ASA class III/IV 43.6%, older than 65 years 58.6%. The most common operations were small bowel resection (20.5%), peptic ulcer repair (12.0%), adhesiolysis (11.8%) and Hartmann's procedure (11.5%). 30‐day post‐operative mortality reached 16.3% and serious complications occurred in 10.9%. Factors associated with post‐operative mortality were increasing age and ASA class, dependent functional status, ascites, severe sepsis, septic shock, and diabetes. HELAS cohort showed similarities with NELA patients in terms of demographics and preoperative risk. Post‐operative utilisation of ICU was significantly lower in the Greek cohort (25.8% vs 56.8%) whereas 30‐day post‐operative mortality was significantly higher (16.3% vs 8.7%).Conclusion: In this study, Greek patients experienced markedly worse mortality after emergency laparotomy compared with their British counterparts. This can be at least partly explained by underutilisation of critical care by surgical patients who are at high risk for death.